← Back to Search

Behavioural Intervention

Group 1: Active CES for Anxiety

N/A

Recruiting

Research Sponsored by David Moss

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Active Duty and DoD Beneficiaries aged 18 or older

Threshold Generalized Anxiety symptoms based on MINI scoring and GAD-7 score of 10 or higher

Timeline

Screening 3 weeks

Treatment Varies

Follow Up visit 8 (week 10)

Awards & highlights

Study Summary

This trial aims to test the effectiveness of CES as a treatment for generalized anxiety in military personnel. The trial will compare CES with a placebo treatment.

Who is the study for?

This trial is for active duty military and DoD beneficiaries over 18 who can receive care at Nellis Air Force Base. Participants must show signs of anxiety with specific scores on the MINI and GAD-7 assessments.Check my eligibility

What is being tested?

The study tests Alpha-Stim 100, a device providing Cranial Electrotherapy Stimulation (CES), against a sham device to see if it helps reduce anxiety symptoms in participants.See study design

What are the potential side effects?

While not specified here, CES devices like Alpha-Stim may cause mild side effects such as headache, dizziness, or skin irritation at the electrode sites.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 and either active duty or a DoD beneficiary.

Select...

I have been diagnosed with moderate to severe anxiety.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ visit 8 (week 10)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~visit 8 (week 10)

This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 8 (week 10) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Beck Anxiety Inventory (BAI)

Hamilton Anxiety Rating Scale (HAM-A)

Heart Rate Variability (HRV)

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Group 1: Active CESExperimental Treatment1 Intervention

Active CES treatment at home 40 minutes daily for 6 weeks

Group II: Group 2: Sham CESPlacebo Group1 Intervention

Sham CES treatment at home 40 minutes daily for 6 weeks

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

David MossLead Sponsor

3 Previous Clinical Trials

558 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently being enrolled in this research study?

"Indeed, according to the details provided on clinicaltrials.gov, this current medical trial is actively searching for eligible participants. The initial posting of the trial information was made on January 1st, 2024, and it has been recently updated as of January 12th, 2024."

Answered by AI

What is the current number of individuals being enrolled in this research investigation?

"Indeed, the information provided on clinicaltrials.gov indicates that this trial is actively seeking participants. The trial was initially posted on January 1st, 2024 and most recently updated on January 12th, 2024. In total, they aim to recruit 160 individuals from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Novel Mental Health Therapies to Improve Military Readiness

David Moss 2024. "Novel Mental Health Therapies to Improve Military Readiness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05887713.